EXFY — what changed in the latest 10-Q
A section-by-section comparison of EXFY's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-08-06 vs the prior 10-Q · 2026-05-07
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +34 | −24 | ~9 | 28 |
| Market risk (Item 3) | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Controls & procedures | Text added/removed | 0 | 0 | ~1 | 2 |
| Legal proceedings | Text added/removed | +1 | 0 | ~2 | 5 |
| Risk factors | Text added/removed | +1 | −3 | ~2 | 1 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Not shown (absent or not faithfully extractable): Other information
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-08-06
Revenue, net decreased $1.9 million, or 5%, for the three months ended June 30, 2026 compared to the same period in 2025, primarily due to (i) a decrease in billable activity across our user base, and (ii) an increase in contra revenue related to cashback payments driven by the increased adoption an…
Cost of revenue, net increased $0.3 million or 2% for the three months ended June 30, 2026 compared to the same period in 2025, primarily due to an increase in amortization expense related to capitalized software. The increase was partially offset by savings generated from the increased use of artif…
Gross margin decreased to 48% for the three months ended June 30, 2026 compared to 52% in the same period in 2025 due to the factors described in the preceding paragraphs for Revenue, Net and Cost of revenue, net.
Research and development expenses decreased by $0.2 million, or 3%, for the three months ended June 30, 2026 compared to the same period in 2025, primarily due to a decrease in internal employee time spent on project initiatives and new product features.
Sales and marketing expenses decreased $9.7 million, or 67%, for the three months ended June 30, 2026 compared to the same period in 2025, primarily due to elevated advertising spend in 2025 related to our title sponsorship of F1® The Movie, which was released in theaters in June 2025.
Text removed vs the prior filing · source: 10-Q · 2026-05-07
COMPARISON OF THE THREE MONTHS ENDED MARCH 31, 2026 AND 2025
Revenue, net decreased $2.1 million, or 6%, for the three months ended March 31, 2026 compared to the same period in 2025, primarily due to (i) a decrease in billable activity across our user base, and (ii) an increase in contra revenue related to cashback payments driven by the increased adoption a…
Cost of revenue, net remained consistent for the three months ended March 31, 2026 compared to the same period in 2025.
Gross margin decreased to 48% for the three months ended March 31, 2026 compared to 51% in the same period in 2025 due to the factors described in the preceding paragraph for Revenue, Net.
General and administrative expenses decreased $1.7 million, or 16%, for the three months ended March 31, 2026 compared to the same period in 2025, primarily due to a decrease in (i) settlement losses, net of recoveries, (ii) employee time spent on general and administrative activities, and (iii) acc…
Legal proceedings
Text added vs the prior filing · source: 10-Q · 2026-08-06
Action. The Derivative Defendants deny the allegations of wrongdoing and will continue to vigorously defend against the claims in the Derivative Action.
Risk factors
Text added vs the prior filing · source: 10-Q · 2026-08-06
Although we have regained compliance with Minimum Bid Price Requirement, it is possible that we could fall out of compliance again in the future. If we fail to meet all applicable Nasdaq requirements in the future and Nasdaq determines to delist our common stock, which would adversely impact liquidi…
Text removed vs the prior filing · source: 10-Q · 2026-05-07
If we do not regain compliance with the Minimum Bid Price Requirement by October 14, 2026, we may be eligible for additional time to regain compliance. To qualify, we would be required to transfer to The Nasdaq Capital Market and meet the continued listing requirement for market value of publicly he…
Staff that we will not be able to cure the deficiency, or if the Company is otherwise not eligible, Nasdaq will provide notice that our securities are subject to delisting, at which point we would have an opportunity to appeal the delisting determination to a hearings panel.
We intend to monitor the closing bid price of our Class A common stock and may, if appropriate, consider available options to regain compliance with the Minimum Bid Price Requirement, including potentially seeking to effect a reverse stock split. However, there can be no assurance that we will be ab…
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice